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Abstract The blood–brain barrier (BBB) is essential for
maintaining homeostasis within the central nervous system
(CNS) and is a prerequisite for proper neuronal function. The
BBB is localized to microvascular endothelial cells that strict-
ly control the passage of metabolites into and out of the CNS.
Complex and continuous tight junctions and lack of fenestrae
combined with low pinocytotic activity make the BBB endo-
thelium a tight barrier for water soluble moleucles. In combi-
nation with its expression of specific enzymes and transport
molecules, the BBB endothelium is unique and distinguish-
able from all other endothelial cells in the body. During
embryonic development, the CNS is vascularized by angio-
genic sprouting from vascular networks originating outside of
the CNS in a precise spatio-temporal manner. The particular
barrier characteristics of BBB endothelial cells are induced
during CNS angiogenesis by cross-talk with cellular and
acellular elements within the developing CNS. In this review,
we summarize the currently known cellular and molecular
mechanismsmediating brain angiogenesis and introduce more
recently discovered CNS-specific pathways (Wnt/β−catenin,
Norrin/Frizzled4 and hedgehog) and molecules (GPR124)
that are crucial in BBB differentiation and maturation.
Finally, based on observations that BBB dysfunction is asso-
ciated with many human diseases such as multiple sclerosis,
stroke and brain tumors, we discuss recent insights into the
molecular mechanisms involved in maintaining barrier char-
acteristics in the mature BBB endothelium.
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Introduction
The developing vertebrate central nervous system (CNS) de-
rives from the ectoderm germ cell layer, a tissue that is devoid
of vascular progenitor cells and that therefore lacks the capac-
ity to generate endothelial cells. Growth of the CNS thus
depends on the delivery of oxygen and nutrients from blood
vessels that invade the brain from the surrounding mesoderm.
Classic studies on embryonic CNS vascularization of the
chick, rat and rabbit cerebral cortex by using a combination
of India ink perfusion and light and transmission electron
microscopy have revealed that blood vessels first form a
perineural vascular plexus (PNVP) and then invade the neural
tube and branch in a precise spatio-temporal manner (Bär
1983; Freeney and Watterson 1946; Strong 1964).
Subsequent studies have confirmed that the development of
the CNS vasculature begins via the process of vasculogenesis,
whereby mesoderm-derived angioblasts invade the head re-
gion and coalescence to form the PNVP, a primitive vascular
network that covers the entire surface of the neural tube at 7.5-
8.5 days post-conceptionem (dpc) in mouse embryos (Hogan
et al. 2004). Starting at 9.5 dpc, vascular sprouts originating
from the PNVP radially invade the neuronal tube, elongage
toward the ventricular zone, form a series of lateral branches at
near right angles and finally anastomose with adjacent
sprouts to produce a subventricular plexus of undifferentiated
capillaries in the ventricular zone of the developing brain
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(summarized in Engelhardt 2003). Vascularization of the CNS
therefore occurs by a process of new vessels being formed
from pre-existing ones, i.e., by angiogenesis (Risau 1997).
The rate of angiogenesis increases until the early postnatal
period thus ensuring a reproducible pattern of CNS vascular-
ization in mammals (Fantin et al. 2013; summarized in
Engelhardt 2003)
The development of BBB-defining features is not in-
trinsic to brain endothelial cells. Indeed, maturation of
barrier characteristics in brain endothelilal cells in the
vascular sprouts requires cross-talk with cellular and mo-
lecular elements from the developing CNS as shown by
elegant chicken to quail (Stewart and Wiley 1981) or quail
to chicken (Ikeda et al. 1996) transplantation studies, in
which embryonic brain tissue from the one species was
transplanted into ectopic sites of embryos of the other
species. The embryonic brain tissue grafts were
vascularized by sprouting angiogenesis from the non-
brain host and developed BBB characteristics including
the expression of BBB-specific molecules (Ikeda et al.
1996), thus providing experimental evidence that endothe-
lial cells from invading host vessels differentiate into
BBB-forming vessels under the influence of the premature
neuroectoderm. Because of the unique structural relation-
ship of astrocyte end feet ensheathing brain microvessels
in the adult brain, astrocytes have long been considered as
the main source of BBB-inducing signals. However, bar-
rier induction most likely takes place well before astro-
cytes differentiate; hence, neuroblasts are speculated to
contribute to BBB differentiation (summarized in Bauer
and Bauer 2000). This barrier-inductive capacity of
neuroblasts has been confirmed more recently in experi-
ments that also implicate neuroblast-derived Wnt growth
factors in this process (Lippmann et al. 2012; Weidenfeller
et al. 2007). Other recent reports have, however, indicated
that pericytes are necessary for the formation and regula-
tion of the BBB (Armulik et al. 2010; Daneman et al.
2010b) and suggest that all cells of the neurovascular unit
(NVU) contribute, to some extent, to the BBB phenotype
of endothelial cells.
With regard to the exact time of maturation of the BBB as a
physical diffusion barrier during embryonic development,
data from the literature are still somewhat controversial.
Early studies described the vascular sprouts invading the
developing CNS as primitive sinusoids with diaphragmed
fenestrae and punctate tight junctional areas; these sprouts
rapidly mature during development by losing their fenestrae,
developing complex tight junctional strands and forming
thin-walled smaller vessels of a regular shape (summarized
in Stewart 2000). In apparent contrast to these observations,
vascular sprouts have been observed to be tight for serum
proteins from the earliest stages of invasion into the develop-
ing CNS (summarized in Saunders et al. 2012).
Development of the BBB
Common angiogenic factors in CNS vascularization
After its discovery in 1989, vascular endothelial cell growth
factor (VEGF) and its endothelial tyrosine kinase receptors
VEGFR1 (Flt-1) and VEGFR2 (Flk-1) were rapidly shown to
be crucial for CNS angiognesis. VEGF is expressed and
released by neural progenitors in the ventricuar neurectoderm
and induces the ingrowth of capillaries from the PNVP (Raab
et al. 2004). Alternative splicing from a single gene produces
VEGF isoforms that differ by the absence or presence of
heparin-binding domains and thus their ability to attach to
the extracellular matrix. Release of these various isoforms is
critical for the production of a VEGF scaffold providing
spatially restricted stimulatory cues that regulate the vascular
branch pattern during brain angiogenesis (Ruhrberg et al.
2002). Extracallular VEGF gradients (Fig. 1) are recognized
by VEGFR2-expressing endothelial cells at the tip of the
vascular sprouts forming filopodial extensions and are there-
fore referred to as endothelial tip cells (Gerhardt et al. 2003).
Correct filopodial guidance additionally relies on the
semaphorin/VEGF coreceptor neuropilin 1 (Nrp1), which
specifically recognizes heparin-binding isoforms of VEGF
(Gu et al. 2003). Stalk cells are endothelial cells localized in
the vascular sprout behind the tip cell and proliferate in a
VEGF-dependent manner, thus ensuring elongation of the
vascular sprout and formation of a vascular lumen
(sumarized in Geudens and Gerhardt 2011). Specification of
the vascular tip versus stalk cells is mediated by the Notch
signaling pathway whereby interaction of the Delta-like 4
(Dll4) ligand with Notch-1/-4 receptors inhibits tip cell and
promotes stalk cell differentiation (Phng and Gerhardt 2009).
Stalk cells down-regulate the expression of VEGFR2 and
express higher levels of the decoy receptor VEGFR1, thus
becoming less sensitive to VEGF. Interestingly, the anastomo-
sis of neighboring tip cells to establish vascular circuits be-
tween the individual vascular sprouts has recently been shown
to be promoted by macrophages expressing the receptor tyro-
sine kinase Tie2 and Nrp1, which invade the embryonic CNS
independently of the blood vessels (Fantin et al. 2010).
Furthermore, migrating endothelial cells produce platelet-
derived growth factor B (PDGF-B), which engages its recep-
tor PDGFR-β on pericytes promoting pericyte recruitment to
the immature vascular structures. Mice lacking either PDGF-
B or PDGFR-β show a complete pericyte loss from brain
microvessels and develop lethal microaneurisms late during
embryongenesis, demonstrating that PDGF-B is actively in-
volved in the vascularization of the brain (Lindahl et al. 1997).
Precise extracellular matrix deposition of PDGF-B is essential
for correct pericyte recruitment to the developing CNS vascu-
lature, as genetic ablation of PDGF-B extracellular matrix
retention sites leads to abnormal pericyte recruitment
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(Lindblom et al. 2003) and perturbed BBB integrity (Armulik
et al. 2010; Daneman et al. 2010b), demonstrating that
pericytes are involved in the differentiation and maturation
of the BBB.
In addition to VEGF and Notch signaling pathways, nu-
merous other molecular mediators of angiogenesis including
the receptor tyrosine kinases Tie-1 and Tie-2, the Tie-2 ligands
Angiopoietin-1 (Ang-1 and Ang−2 (Fig. 1), members of the
transforming growth factor (TGF)-β superfamily and the
EphB-receptor/ephrinB-ligand family together orchestrate an-
giogenesis in the CNS but also elsewhere in the organism
(summarized in Adams and Alitalo 2007). Moreover, junction
proteins such as VE-cadherin, not only contribute to vascular
stability and endothelial polarity but also play a vital role in
the regulation of the endothelial response to pro- and anti-
angiogenic stimuli (Dejana and Vestweber 2013).
Although we have thus obtained deep insight into the
mechanisms involved in brain angiogenesis, none of those
mechanims solely applies to CNS angiogenesis and therefore
none is a likely candidate to direct CNS endothelial cells
toward their unique BBB phenotype.
CNS-specific regulators of angiogenesis:
the G-protein-coupled receptor, GPR124
The orphan G-protein-coupled receptor GPR124/TEM5 has
recently been described as the first essential endothelial recep-
tor specifically involved in CNS angiogenesis independent of
Fig. 1 Differentiation of the blood–brain barrier (BBB). Left Angiogen-
esis phase. Vascular sprouts radially invade the embryonic neuroectoderm
toward a concentration gradient of vascular endothelial cell growth factor-
A (VEGF), which is produced by neuroectodermal cells located in the
ventricular layer (EC endothelial cell, NPC neuronal precursor cell, dpf
days post-fertilization). Growth factors such as the endothelial-cell-spe-
cific receptor tyrosine kinase Tie-2 and its ligands angiopoietin-1 (Ang-1)
and angiopoietin-2 (Ang-2) are involved in angiogenic sprouting early
during embryogenesis, together with the morphogens Wnt7a/7b/3a,
Norrin and potentially sonic hedgehog (Shh). Middle Differentiation
phase. The phenotype of cerebral endothelial cells changes such that they
down-regulate their expression of the MECA-32 antigen. In this phase,
the anti-angiogenic barrier-inducing signals start to overrule the pro-
angiogenic signals. Shh, Norrin and Ang-1 are produced by differentiating
astrocytes. Tie2- and neuropilin 1 (Nrp1)-expressing myeloid cells pro-
mote anastomosis of tip cells to establish vascular circuits (PC pericyte,
AC astrocyte, N neuronal cell). Right Maturation phase. Despite the
cerebral endothelial cells forming the barrier proper, close contact with
PCs, ACs and possibly Ns is required for the maintenance of the BBB
(MG microglial cell, P4 postnatal day 4). The molecular mechanisms
involved in this cross-talk required for BBB maintenance in the mature
central nervous system (CNS) remain largely unknown but Norrin/Friz-
zled4 signaling, in particular, seems to be important, at least in specific
regions of the CNS (olfactory bulb, cerebellum, retina; see Fig. 2)
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VEGF (see above) and Wnt/β-catenin (see below) signaling
(Cullen et al. 2011; Kuhnert et al. 2010). In the developing
CNS, GPR124 is specifically expressed in the endothelium and
functions cell-autonomously. Although the expression of
GPR124 is not limited to specific vascular segments,
GPR124 regulates endothelial cell sprouting and migration in
the developing forebrain and spinal cord but not in the dien-
cephalon, midbrain and hindbrain suggesting a corresponding
embryonic spatial restriction of either GPR124 ligands or
GPR124 signaling in endothelial cells and adding yet another
level of complexity to CNS angiogenesis. Genetic ablation of
GPR124 has demonstrated its role in regulating TGF-β signal-
ing in a CNS-specific manner (Anderson et al. 2011). TGF-β
signaling in endothelial cells has previously been shown to be
involved in CNS angiogenesis, as its absence leads to aberrant
vascular sprouting and hemorrhages. Pericytes and astrocytes
have been identified as cellular sources for TGF-β during CNS
angiogenesis (Garcia et al. 2004; Takata et al. 2007). An
additional role of GPR124 beyond CNS angiogenesis in BBB
differentiation is suggested by the observation that the ablation
of GPR124 also reduces the expression of the BBB marker
Glut-1 (Kuhnert et al. 2010; Table 1).
CNS-specific regulators of angiogenesis and barrier genesis:
morphogens regulating BBB differentiation
The morphogenic Wnt/β-catenin and hedgehog pathways are
additional CNS-specific regulators of angiogenesis (Fig. 1;
Alvarez et al. 2011; Liebner et al. 2011). Morphogens such
as Wnt and hedgehog are considered to be mostly soluble
growth factors that can act in gradients as short- or long-range
factors determining cell-fate decisions during early embryo-
genesis and tissue formation (Table 1; Stathopoulos and Iber
2013).
Wnt proteins are secreted proteins that bind to the N-
terminal cystein-rich domain (CRD) of seven-pass-
transmembrane Frizzled (Fzd) receptors in the presence of
lipoprotein-related-protein receptor 5/6 (LRP5/6). The secre-
tion and biological activity of Wnts are highly dependent on
various post-translational modifications, which, in the case of
Wnts, are glycosylation on the one hand and the addition of a
palmitoleic acid at conserved serine residues, on the other
hand (Willert and Nusse 2012). Glycosylation appears to be
crucial for the subsequent acylation that is probably conferred
by the protein porcupine (Porcn), which is resident in the
endoplasmic reticulum. At least for mouse Wnt3a, the Porcn
is essential for a functional Wnt3a protein (Takada et al.
2006). Apparently, the post-translational modifications of
Wnt growth factors also determine their solubility and thereby
their biological action as diffusible cell-membrane- or
extracellular-matrix-bound factors. These properties of Wnts
should be kept in mind when considering their release from
one cell type acting on another, as for example in the NVU. So
far, the Wnt factors have been described to act in three,
relatively independent pathways, known as the “canonical”
β-catenin-dependent pathway and the two non-canonical
pathways acting via Ca++/proetin kinase C (PKC)/calmodulin
or c-jun N-terminal kinase (Rao and Kuhl 2010).
The β-catenin “canonical” Wnt signaling pathway (better
referred to as theWnt/β-catenin pathway) is the best described
so far. Herein, the structural adherens junction protein β-
catenin, which links classic cadherins via α-catenin to the
Table 1 Regulators of angiogenesis specific to the central nervous
system (CNS) and particularly the blood-brain barrier (TGF-β
transforming growth factor-β, ZO-1 zonula occludens-1, Shh sonic
hedgehog, GPR124 G-protein-coupled receptor, SSeCKS src-suppressed
C-kinase substrate, plvap1 plasmalemma vesicle associated protein 1)
Factor Barrier-supporting Barrier-diminishing Reference
β1-Integrin-mediated adhesion
of endothelial cells to laminin
Expression of claudin-5
Norrin Up-regulation of Glut-1, claudin-5;
down-regulation of plvap/meca32
Wang et al. 2012
β-Catenin Induction of claudin-3 Liebner et al. 2008
Wnt3a/Wnt7a/b Induction of claudin-3, Glut-1 Daneman et al. 2009;
Liebner et al. 2008;
Stenman et al. 2008
Shh Immunoquiescence; regulation of
claudin-5, occludin
Alvarez et al. 2011
Nogo-A Inhibition of CNS
angiogenesis
Wälchli et al. 2013
GPR124 Induction of Glut-1
TGF-β signaling in CNS endothelial cells
Anderson et al. 2011;
Cullen et al. 2011;
Kuhnert et al. 2010
SSeCKS Induction of angiopoietin-1 Lee et al. 2003
Retinoic acid Induction of pGP, ZO-1, occludin
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actin cytoskeleton, acts as a co-transcription factor together
with lymphoid enhancer factor/T-cell factor (Lef/TCF), medi-
ating the regulation of cellular responses such as the cell cycle,
apoptosis, cell differentiation and cellular communication
(Klaus and Birchmeier 2008; Table 1).
In the developing CNS of vertebrates, the Wnt/β-catenin
pathway has been studied in particular detail and a wide range
of functions such as the determination of the midbrain-
hindbrain boundary and the patterning of the telencephalon
have been described. Herein, the cortical border acts as a
signaling center, providing instructive Wnt cues for hippo-
campal development (Lee et al. 2000). Because of the many
individual ligands (19 Wnt genes) and Fzd receptors (11 Fzd
receptors), the differential expression of these factors has not
been comprehensively studied in the developing mouse em-
bryo in general. However, in the CNS, the expression pattern
of the most-studied Wnt growth factors (Wnt-1, -3,-3a, -5a,
-7a, -7b) have been described in more detail (Parr et al. 1993).
Interestingly, at early time points of neural tube closure (8.0-
8.5 dpc), Wnt-1, -3a and -7b are expressed in defined do-
mains, whereas approximately 1 day later (9.0-9.5 dpc), the
expression of these Wnt factors almost completely encircles
the presumptive brain and spinal cord. However, individual
Wnts are expressed in distinct domains, of which Wnt-1/-3/
-3a are dorsally distributed, whereas Wnt-7a/-7b show a ven-
tral expression pattern. Wnt-4 shows a unique broad dorsal
distribution and, in addition, is heavily expressed in the floor
plate, suggesting a specific function in dorsal and ventral
differentiation. Interestingly, Daneman et al. (2009) described
that, at 11.5 dpc, the expression of Wnts acquires an even
more defined pattern, while maintaining the gross distribution
observed at 9.5 dpc.
In this context, the localized expression of the factors
determined to date to regulate some aspect of the BBB phe-
notype has to be considered. As mentioned above, GPR124 is
only detectable in the forebrain and spinal cord, whereas other
factors such as the non-Wnt-related Fzd-4 ligand Norrin is
only expressed in the retina, olfactory bulb and cerebellum.
These regional differences, which are mainly detectable in the
developing CNS (Fig. 2), further underline that “the BBB
phenotype” probably does not exist but is instead defined by
the expression of various sets of genes that make CNS micro-
vascular endothelial cells act as an entity, unique and different
from peripheral endothelial cells. Equally, the defined spatial
distribution of Wnts, sonic hedgehog (Shh) and GPR124
during development further suggests that there is probably
no such thing as a “one barrier-inducing pathway” but instead
favors the interpretation that, depending on their final desti-
nation within the CNS, micovascular endothelial cells receive
localized molecular cues, inducing “just the right” flavor of
the BBB.
In vertebrates and particularly in mammals, the hedhehog
(Hh) pathway is activated by the binding of one of the three
identified ligands, namely sonic (Shh), desert (Dhh), or indian
hedgehog (Ihh), to the 12-pass transmembrane receptor
patched (Ptch). Ligand binding to Ptch releases its repression
on the 7-pass transmembrane receptor smoothened (Smo), a
member of the G-protein-coupled receptor (GPCR) family.
Phosphorylation of Smo by PKA and/or G-protein–coupled
receptor kinase 2 leads to the translocation of Smo into the
membrane domain of the primary cilium, a structure present in
most, if not all, vertebrate cells, rendering Smo active and
leading to the conversion of Gli transcription factors from a
repressive to an active state. In vertebrates, threeGli transcrip-
tion factors, Gli1, 2 and 3, have been described, belonging to
the zinc-finger family of transcription factors (Briscoe and
Thérond 2013). Interestingly, the three members have distinct
functions. Gli1 is itself a direct target of Hh signaling and
provides a positive feedback, with Gli3 mainly acting as a
repressor of the pathway. Current knowledge indicates that
Fig. 2 Expression of the described barrier inducing factors in the adult
mouse brain. Representation of the available global expression data of
barrier-inducing factors in the adult mouse brain. Note the minimal
overlap but the rather distinct regional expression of the individual factors
suggesting site-specific induction/maintenance cues for endothelial barri-
er properties in the CNS (SVZ subventricular zone, Shh sonic hedgehog,
GPR124 G-protein-coupled receptor)
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Gli2 is the main signal-transducing transcription factor in Hh
signaling.
Shh is probably the best-described ligand in the Hh path-
way and its genetic deletion in mice leads to lethality at late
embryonic or perinatal stages because of abnormalities in the
eye, brain and axial patterning (Chiang et al. 1996). In
humans , mu t a t i on s i n t h e Shh gene l e ad s t o
holoprosencephaly type 3 HPE3 attributable to aberrant de-
velopment of the ventral midline (Maity et al. 2005; Table 1).
The diffusible properties of the Hh ligands differ consider-
ably from those of the Wnt factors described above, in the
sense that Shh, for example, can form diffusible gradients over
long distances. Consequently, the locally available concentra-
tion of Shh crucially influences the response of target cells, for
example, in limb bud development (Lum 2004).
Interestingly, Shh has recently been described by Alvarez
and colleagues (2011) to be released by astrocytes in the adult
brain and to contribute to BBB integrity during the steady
state of the BBB and, in particular, in BBB impairment during
inflammatory disease. In contrast, astrocytes seem to express
Shh especially under activated conditions, such as ischemia
and experimental oxygen-glucose deprivation and to activate
proliferation, migration and tube formation in brain endothe-
lial cells via the RhoA/Rho-associated protein kinase (ROCK)
pathway (He et al. 2013). Although the studies and the exper-
imental settings (in vivo vs. in vitro) are not directly compa-
rable, we have to understand the mechanisms of the differen-
tial effects elicited by Shh in CNS endothelial cells.
As a first step toward the understanding of Shh function in
the adult mammalian brain in general and in BBB integrity in
particular, the expression pattern of Shh in the adult needs to be
explored in more detail at the cellular level, possibly by apply-
ing genetically inducible, fate-mapping studies for the Shh and/
or Wnt genes (Blaess et al. 2011). So far, only little information
is available regarding the expression of Shh in the postnatal or
adult mammalian CNS. Probably the best described sites of Shh
expression are the Purkinje cells of the cerebellum; these cells
act on granule cells in the external germinative layer. The latter
cells are sensitive to Shh and pathway over-activation might
lead to the formation of malignant medulloblastoma (Northcott
et al. 2011). However, Shh can also be down-regulated in the
cerebellum of the adult mouse and human brain.
Interestingly, Shh is also involved in adult neurogenesis in
the subventricular zone (SVZ), at which the factor is produced
and released by specific ventral neurons and influences the
generation of deep granule neurons (Ihrie et al. 2011). This
finding is particularly interesting, as it has been suggested that
vessels in the SVZ, which play a crucial role in adult
neurogenesis by providing the so-called vascular niche, dis-
play reduced BBB characteristics (Shen et al. 2008; Tavazoie
et al. 2008). Whether vessels in the SVZ respond to Shh
released by deep granule neurons is currently a matter of
speculation and needs further investigation.
In the developing CNS, however, the expression of Shh has
been extensively studied and its expression is mainly con-
fined to the notochord and to the floor plate at the ventral side
of the neural tube, thereby defining ventral identity (Wilson
and Maden 2005). In contrast, dorsal cues are provided by
Wnt and bone morphogenetic proteins (BMPs), which coun-
teract Shh signaling via the regulation of Gli3 acting as a Shh
transcriptional inhibitor (Ulloa and Martí 2010). In the devel-
oping CNS, Shh and Wnt growth factor expression, as far as
we can judge from the available data, do not overlap on a large
scale, suggesting that no systematic co-expression occurs
correlating with the onset of angiogenesis and BBB differen-
tiation in the various regions of the premature CNS.
At the cellular level, however, both Shh and and almost all
Wnt factors are expressed by differentiated isolated astrocytes
(Alvarez et al. 2011; He et al. 2013; own unpublished
observations).
Notably, Shh has previously been reported to induce the
angiogenic factor angiopoietin-1 (Ang-1) and to repress
angiopoietin-2 (Ang-2), leading to increased signaling via
the receptor tyrosine kinase Tie2 (Lee et al. 2007). In this
regard, astrocytes have been shown to up-regulate Ang-1
downstream of src-suppressed C-kinase substrate (SSeCKS),
contributing to junction protein expression and vascular mat-
uration (Lee et al. 2003; Table 1). Taking these findings
together, we are tempted to speculate that Shh and SSeCKS
act synergistically or in parallel in astrocytes; however, auto-
crine stimulation of the Hh pathway in astrocytes has not been
described as yet.
The proposal that Ang-1 is an interesting mediator of
vascular stability on the one hand but also of barrier proper-
ties on the other, is further supported by a recent publication
showing that Ang-1 positively regulates β-catenin signaling
in endothelial cells by phosphorylation of GSK3β via Akt,
ultimately leading to the up-regulation of delta-like 4/Notch
signaling, which is a master regulator of endothelial quies-
cence (Phng et al. 2009; Zhang et al. 2011). These findings
conceptually agree with reports of Dll4 regulation by Wnt/β-
catenin in developmental and pathological angiogenesis con-
tributing to vascular maturation and quiescence (Corada et al.
2010; Reis et al. 2012).
Regarding the development of blood vessels in the CNS,
Wang and colleagues (2013) more recently identified the
leucine-rich alpha-2-glycoprotein 1 (Lrg1) as being involved
in vascular growth under pathologic conditions in the retina.
The authors showed that Lrg1 directly interacts with the
endothelial-specific TGFβ co-receptor endoglin/CD105,
thereby regulating TGFβ-induced differential activation of
either smad1/5 or smad2/3 and, through this, regulating endo-
thelial proliferation of retinal and brain endothelial cells. At
this point, the contribution of Lrg1 to brain angiogenesis and
BBB differentiation is unknown but endothelial Lrg1 defi-
ciency might interfere with the proper formation of the brain
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vasculature, similar to the defects observed in endoglin/
CD105 heterozygous mice, which represent a model of he-
reditary hemorrhagic telangiectasia type 1 (Satomi 2003).
Interestingly, as mentioned above, deficiency of GPR124
also affects angiogenesis and vascular integrity via the mod-
ulation of the TGF-β pathway in a brain-specific manner.
Together, these observations suggest that CD105/endoglin
and Lrg1 interact with the GPR124-TGF-β signaling axis.
A more direct and specific effect for brain angiogenesis has
recently been described for the long-known axonal guidance
inhibitor Nogo-A (Wälchli et al. 2013; Table 1). Briefly, the
Nogo-A-pecific Delta 20 domain directly mediates endotheli-
al growth inhibition via a Rho-A/ROCK-Myosin-II-depen-
dent mechanism, leading to the retraction of lamellipodia
and filopodia. Of interest, the effect of Nogo-A is probably
more profound than just the inhibition of the lamelli-/filopodia
in tip cells, as Phng and colleagues (2013) have reported that
filopodia are dispensable for endothelial tip cell guidance. As
Shh has been shown to regulate angiogenesis via the
RhoA/ROCK pathway, Nogo-A might act as an antagonist
of Shh signaling.
The observation that the developmental pathways of Wnt
and Shh contribute to BBB induction, differentiation and even-
tually maintenance (see below) appears to have been a research
“catalyst”, as more recently, the developmentally active retinoic
acid pathway has been demonstrated to induce BBB character-
istics in endothelial cells (Mizee et al. 2013; Table 1). Given the
identification of the various pathways and pathway “flavors”
involved in BBB induction and differentiation, the challenge for
the future will be to understand their concerted action.
A first step toward this might be the recent observation that
the T-box transcription factor Tbx1 is involved in the vascu-
larization of the brain (Cioffi et al. 2013), in a strikingly
similar manner to Wnt7a/b (Daneman et al. 2009; Stenman
et al. 2008). Interestingly, Tbx1 is believed to be the major
mutated gene in DiGeorge syndrome, a human hereditary
disease leading to mental retardation attributable to vascular
malformations; Tbx1 has previously been described to be
downstream of Wnt/β-catenin in non-endothelial cells (Huh
and Ornitz 2010).
Barrier characteristics during development
As outlined above, the CNS acquires its vasculature solely by
angiogenesis (for a review, see Liebner et al. 2011). During the
angiogenesis phase, which starts in rodents at about 9.0 dpc,
vessels of the PNVP cover the entire brain and start radially to
invade the neuroectodermal tissue (Fig. 1). At this stage,
endothelial barrier characteristics are immature with regard
to the distribution of luminal and abluminal Glut-1 and the
high expression of the pan-endothelial cell MECA-32 antigen
(also known as plasmalemma vesicle associated protein 1,
Plvap1) and with regard to the expression and localization of
tight junction proteins, such as claudin-5 and claudin-3
(Liebner et al. 2011).
On the other hand, ample evidence is available showing
that even the first vessels that grow into the avascular
neuroectoderm are relatively tight to blood-borne proteins,
such as albumin and immunoglobulin (for a review, see
Saunders et al. 2012). This is in agreement with our finding
that even vessels of the PNVP receive and respond to Wnt
signals at 9.5 dpc, prior to entering the neuroectoderm
(Liebner et al. 2008). Nevertheless, fetal brain vessels exhibit
different, and in part increased, transport properties for amino
acids and other metabolites, coinciding with higher demands
for nutrients or a neuroprotective mechanism in the developing
CNS (for reviews, see Saunders et al. 2012; Stewart 2000).
Furthermore, some tight junction proteins, in particular the
Wnt/β-catenin-regulated claudin-3, show increased expres-
sion and cell-cell-contact restricted localization with increas-
ing age, specifically at postnatal stages (Liebner et al. 2008).
Not ignoring the fact that the specific function of claudin-3 in
endothelial cells is currently not known and the specificity for
BBB still has to be determined, these findings highlight the
continuous nature of BBB maturation during development.
Although blood vessels that invade the neuroectoderm
during early embryogenesis do not exhibit marked leakiness
to endogenous and exogenous traces of various sizes, the
physiological demands on the fetal and the adult BBB are
nevertheless strikingly different. This is also supported by the
early postnatal lethality of claudin-5-deficient mice, which
exhibit an increased leakiness for small-molecular compounds
(<800 Da; Nitta et al. 2003). Apparently, this defect, i.e.,
leakiness, can be tolerated during embryogenesis as long as
the placental barrier is in place and functional. In turn, this
finding does not necessarily imply that the fetal barrier is
“leaky”. However, from the view of a developmental biolo-
gist, a developing organ system is unlikely to share the same
properties as the adult system, strongly indicating the exis-
tence of some degree of “immaturity”. Indeed, in the mam-
malian brain and in particular in rodents, angiogenic activity
in the cortex well proceeds until 2–3 weeks after birth (Caley
and Maxwell 1970). As angiogenic vessels do not exhibit
mature properties with regard to pericyte coverage and junc-
tional organization, BBB properties probably also require
some refinement. This is further reflected by a recent unbiased
screening of early postnatal versus adult brain endothelial
cells, in which several hundreds of genes were found to be
differentially regulated between early postnatal and adult
stages, suggesting a dramatic switch in molecular and proba-
bly physiological properties (Daneman et al. 2010a). A
comparision of early with late embryonic or early postnatal
brain vessels would therefore be interesting, although techni-
cally challenging.
Thus, although barrier maturation in brain endothelial cells
might not take place in two sequential phases as previously
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suggested by us (Engelhardt and Risau 1995), the recent
observations discussed above support the concept of ongoing
barrier genesis in brain endothelial cells during angiogenesis.
Despite the long-lasting and controversial debate about the
“leakiness” of the mammalian fetal BBB, this discussion turns
out to be semantic rather than scientific from the current
perspective, mostly because many authors still equate imma-
turity of the BBB with BBB leakiness during embryonic
development. Thus, although “leakiness” per se has not been
observed in recent studies, the term “immature” however
appears to be appropriate, as it is objectively defined in devel-
opmental biology as a noticeable difference between develop-
mental stages and the adult; this certainly applies to the BBB.
Once fully matured the differentiated BBB consists in a
complex system formed by the highly specialized endothelial
cells and their underlying endothelial basement membrane, in
which a exceptionally large number of pericytes is embedded
(Armulik et al. 2011). Microvessels are further enveloped by a
second parenchymal basement membrane and astrocyte
endfeet. Continuous cross-talk between the cellular and acel-
lular elements of the NVU is required to control the restricted
movement of molecules, ions and cells across the BBB
(summarized in Engelhardt and Sorokin 2009).
Maintenance of the mature BBB
Cellular and molecular mechanisms maintaining BBB
integrity under physiological conditions
The unique physiological features of the endothelial cells
forming the BBB comprise a lack of fenestrations, low pino-
cytic activity and the presence of highly complex continuous
tight junctions, the combination of which establishes a phys-
ical barrier. In addition, CNS microvascular endothelial cells
form ametabolic barrier by the polarized expression of plasma
membrane transporters either at the luminal or at the
abluminal side, ensuring the transport of nutrients, ions and
other metabolites into the CNS and of toxic metabolites out of
the CNS (summarized in Abbott et al. 2010; Cecchelli et al.
2007).
In addition to an endothelial basement membrane harbor-
ing a large number of pericytes (Armulik et al. 2011), CNS
microvessels are additionally enveloped by a second
parechymal basement membrane produced by astrocytes.
The astrocytes themselves tightly appose their endfeet onto
the abluminal side of the CNS microvessels. This unique
anatomical set-up of CNS microvessels, which is referred to
as the NVU, suggests that continous cross-talk between the
cellular and acellular elements of the NVU is required to
control endothelial cell polarity and the restricted movement
of molecules, ions and cells across the BBB (summarized in
Engelhardt and Sorokin 2009). This is corroborated by the
observation that, when placed in culture, CNS microvascular
endothelial cells rapidly lose their unique barrier characteris-
tics (Lyck et al. 2009), which however can be partially re-
stored by co-culturing with pericytes or astrocytes (Coisne
et al. 2005; Deli et al. 2005; Hamm et al. 2004; Wolburg
et al. 1994).
In spite of the tremendous recent increase of knowledge
about the molecular mechanisms that are provided by the
neural enrivonment during embryonic development and that
mediate BBB development and differentiation, our compre-
hension of the cellular sources and the molecular signals
involved in maintaining the steady-state of the BBB under
physiological conditions in the adult is limited to date.
Expression levels of some molecules involved in CNS angio-
genesis, such as the VEGF receptors, are down-regulated in
adult quiescent BBB endothelium, as are their ligands in
differentiated cells of the CNS parenchyma and therefore
their continuous role in BBB maintenance has been
questioned. Indeed, the continuous high expression levels of
VEGF in the choroid plexus epithelium and of its receptors in
the choroid plexus vasculature have been shown instead to
maintain endothelial fenestrations in this tissue (Esser et al.
1998).
In contrast, the Wnt/β-catenin pathway might, in addition
to its role in BBB development and differentiation, play a role
in BBB maintenance, as suggested by recent studies per-
formed in zebrafish and mouse models. Specifically, novel
transgenic reporter zebrafish lines recently established for
Wnt/β-catenin signaling convincingly demonstrate the activa-
tion of the green fluorescent protein reporter gene in adult 1-
year-old animals, indicating that Wnt/β-catenin activity is at
least involved in the maintenance of the CNS blood vessel
network of zebrafish (Moro et al. 2012). Additional elegant
studies in mice have shown that, at least in the retina and in the
cerebellum, in which the non-Wnt-family Frzd-receptor ago-
nist Norrin is expressed, adult inactivation of the gene or its
cognate receptor Frzd4 leads to the loss of barrier character-
istics (e.g., expression of claudin-5) and up-regulation of the
permeability-associated gene plvap/meca32 (Wang et al.
2012). Together, these reports strongly suggest that the Wnt/
β-catenin pathway remains operational in endothelial cells of
the adult CNS, providing an essential cue for BBB mainte-
nance. Furthermore, as certain molecular cues have been
shown to display remarkable region-specific effects during
CNS angiogenesis and the induction of endothelial barrier
characteristics (see above) in particular, the work of Wang
et al. (2012) adds this degree of complexity to BBB mainte-
nance in the adult in which different frizzled ligands might
regulate the Wnt pathway in different regions of the CNS,
potentially resulting in different “flavors” of BBB character-
istics. Finally, the observation that radial glia are involved in
nascent vessel stabilization in the cerebral cortex by inhibiting
Wnt/β-catenin signaling in CNS endothelial cells (Ma et al.
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2013) adds yet another piece of knowledge to this mosaic and
further underscores our superficial level of understanding of
the signals and their actual signaling qualities that are respon-
sible for maintaining BBB characteristics in the endothelium
of the CNS.
At the cellular level, the polarized nature of astrocytes, as
visualized by the high accumulation of the water channel
protein aquaporin-4 (AQP4) in astrocyte endfeet surrounding
the CNS microvessels, has been implicated in the regulation
of CNS homeostasis (Liebner et al. 2011). The astrocyte
endfoot is anchored via dystroglycan to the heparan sulfate
proteoglycan agrin, the expression of which is up-regulated
during CNS angiogenesis (Bezakova and Ruegg 2003).
Nevertheless, mechanistic insights into the way that astrocyte
polarity maintains BBB integrity are lacking to date.
A role for pericytes in addition to astrocytes in the mainte-
nance of BBB characteristics has been suggested by a recent
study analyzing a set of adult viable pericyte-deficient mouse
mutants (Armulik et al. 2010). A comparison of these mouse
mutants has shown that a decrease in pericyte coverage di-
rectly correlates with reduced barrier characteristics of CNS
microvessels by increasing endothelial transcytic activity.
Furthermore, this study demonstrated that, in addition to
influencing BBB-specific gene expression patterns in CNS
microvascular endothelial cells, pericytes also induce the po-
larization of astrocyte endfeet surrounding CNS blood ves-
sels. Taken together, these observations nevertheless highlight
that communication between all cellular elements of the NVU,
although already implemented during development, is in-
volved in BBB induction and maintenance. In this respect,
the recent observation that ApoE and, in particular, ApoE4,
which is mainly produced by astrocytes and has previously
been implicated in BBB function, affects BBB function via
the activation of the pro-inflammatory mediator cyclophilin A
(CypA) in pericytes (Bell et al. 2010) needs to be mentioned.
Last but not least, the role of the acellular elements of the
NVU in maintaining BBB characteristics in CNS microvas-
cular endothelial cells has to be considered, especially as CNS
microvessels are surrounded by twomolecularly distinct base-
ment membranes (Engelhardt and Sorokin 2009). In addition
to anchoring astrocyte endfeet, pericytes and endothelial cells
and thus supporting cellular polarity, the extracellular matrix
within the NVU most certainly plays an important role in
trapping soluble mediators such as VEGF and Wnts and
thereby establishes spacial cues for BBB induction and main-
tenance (Kim et al. 2011).
Cellular and molecular mechanisms impairing BBB integrity
under neuropathological conditions
Loss of BBB integrity is a hallmark of a wide variety of
neurological disorders including multiple sclerosis (MS),
stroke, or brain tumors. Distrubance of the molecular cross-
talk between the elements of the NVU in CNS pathology leads
to BBB dysfunction setting the stage for edema formation,
recruitment of inflammatory cells and neuronal cell death. In
this context, the adhesion of cellular elements of the NVU has
been recognized as a critical determinant for BBB integrity.
The spatio-temporal correlation of the rapid loss of β1-
integrin immunostaining and of edema formation in the ische-
mic core in an animal model for stroke (Tagaya et al. 2001)
has suggested that β1-integrin-dependent adhesion of CNS
mirovascular endothelial cells is a prerequisite for BBB integ-
rity. Indeed, β1-integrin-mediated adhesion of brain endothe-
lial cells to laminin in the surrounding endothelial basement
membrane has been demonstrated to be critical for stabilizing
claudin-5 in the tight junctions and integrity of the BBB
(Osada et al. 2011). Thus, a not-as-yet described intracellular
signaling pathway originating from endothelial β1-integrin
engaged in binding to laminin affects the molecular architec-
ture of the tight junctions and thus of the integrity of the BBB.
Interestingly, laminins, and in particular laminin α5, have
been shown to regulate Shh and Wnt/β-catenin signaling in
a cell- and tissue-dependent manner (for a review, see Spenle
et al. 2013).
Moreover, the loss of astrocyte polarity, as visualized as a
loss of the polarized expression of AQP4 to astrocyte endfeet,
has been observed as a hallmark in a number of CNS pathol-
ogies, including animal models of stroke (Steiner et al. 2012)
and multipe sclerosis (Wolburg-Buchholz et al. 2009) and in
human brain tumors (Warth et al. 2005) in which it has been
demonstrated to correlate tightly with BBB dysfunction. In
experimental autoimmune encephalomyelitis, an animal mod-
el of MS, leukocytes localized in the perivascular space after
having penetrated the BBB secrete matrixmetalloproteases
(MMP)-2 and MMP-9, leading to the degradation of the
astrocyte extracellular matrix receptor dystroglycan, which is
a prerequisite for leukocyte penetration across the glia limitans
into the CNS parenchyma (Agrawal et al. 2006). Infiltrating
leukocytes therefore destroys astrocyte foot anchorage, leading
to the loss of astrocyte polarity and eventually BBB integrity.
These data point to an important role of the polarized expres-
sion of astrocyte AQP4 in maintaining BBB integrity; this is
further supported by the observation that BBB breakdown is a
key feature of neuromyelitis optica, a neuroinflammatory
disease, in which antibodies to AQP4 contribute to disease
pathogenesis (Bradl et al. 2009). In apparent contrast to these
observations, genetic ablation of AQP4 in mouse mutants has
been observed not to correlate with BBB dysfunction (Eilert-
Olsen et al. 2012; Haj-Yasein et al. 2011). These observations
therefore highlight the need of inflammatory mediators in the
induction of BBB distrubance, in addition to the loss of
astrocyte polarity, under pathological conditions.
As pointed out above, the morphogenic Shh and Wnt/β-
cateinin signaling pathways recently discovered to be in-
volved in brain angiogenesis and BBB differentiation seem
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to play a continuous role in maintaining BBB integrity. In
addition, these pathways might become re-activated under
inflammatory conditions in the CNS, as they occur in MS.
Hypertrophic astrocytes in active inflammatory demyelinating
lesions in brain tissue from MS patients have recently been
shown to display the elevated presence of Shh accompanied
by the increased immunostaining of Patched-1 and nuclear
localization of Gli-1 in brain endothelial cells (Alvarez et al.
2009). In addition, this study has provided direct evidence for
the induction of the increased expression of components of the
Shh signaling pathway in endothelial cells and astrocytes by
proinflammatory cytokines.
Similar observations have been reported in ischemic brains
in animal models for stroke. Specifically, Shh has been found to
be transiently up-regulated in the focal ischemic brain in an
animal model of stroke (Sims et al. 2009) and inhibition of Shh
signaling leads to aggravated brain edema in an animal model
for acute ischemic stroke (Ji et al. 2012). In this context,
intracerebroventricular injections of Shh have been found to
reduce brain edema and to preserve BBB integrity in an animal
model for ischemic stroke by increasing the expression of
zonula occludens-1, occludin and Ang-1 in the ischemic pen-
umbra (Xia et al. 2013). One is therefore tempted to speculate
that neuroinflammation triggers enhanced astrocyte-endothelial
cross-talk through the Shh pathway in an attempt to maintain
and/or repair the barrier characteristics of the BBB.
Furthermore, an additional feature of the Shh pathway observed
in the context of MS is that Shh seems to establish the
immunoquiescence of brain endothelial cells by inhibiting the
expression of endothelial adhesion molecules required for im-
mune cell trafficking across the BBB. The Shh pathway might
therefore contribute to the maintenance of limited immune cell
migration across the BBB and thus CNS immune privilege.
In brain tumors, BBB integrity is frequently lost because of
tumor-induced angiogenesis and thus the formation of a
nonphysiological vascular phenotype. The observation of the
nuclear localization of β-catenin in blood vessels in
gliobastoma has suggested an as yet unknown involvement
of endothelial Wnt/β-catenin signaling in brain tumor angio-
genesis (Yano et al. 2000). To address the function of endo-
thelial Wnt signaling in glioma angiogenesis, the growth of
experimental gliomas overexpressing either Wnt1 or the Wnt
signaling inhibitor Dickkopf-1 were investigated in our labo-
ratory (Reis et al. 2012). The surprising finding of these
studies was that enforced activation of the Wnt/β-catenin
pathway in these tumors led to reduced tumor angiogenesis
by the up-regulation of Dll4 (Delta-like 4) and increased
Notch signaling in endothelial cellls during tumor
neoangiogenesis. As a consequence of Wnt pathway activa-
tion, the expression of tip cell genes was inhibited, whereas
stalk cell genes were up-regulated, resulting in more quiescent
endothelial cells. Furthermore, enforced Wnt/β-catenin sig-
naling augmented mural cell recruitment, thereby contributing
to vascular quiescence and barrier function. Although these
studies suggest that reinforced Wnt/β-catenin signaling in
brain tumor vessels leads to an inhibition of angiogenesis with
normalized and less permeable vessels, studies in other exper-
imental tumors highlight a proangiogenic function of the
Wnt//β-catenin pathway (Min et al. 2011). Currently, the
determinants of the outcome of Wnt/β-catenin signaling are
unknown in the vascular compartment in general and in the
BBB endothelium in particular. Whether Wnt/β-catenin will
prove to be a valuable therapeutic target for anti-angiogenic
and edema glioma therapy has to be determined in future
studies.
Outlook
The last few years have provided a substantial body of novel
mechanistic insights into the development and differentiation of
the BBB. The unique barrier characteristics established at the
level of CNS microvascular endothelial cells are well
established as being the result of tightly controlled cross-talk
between cellular and acellular elements of the NVU. In partic-
ular, the recent discoveries of the involvement of the morpho-
genic wnt/β-catenin and Shh pathways not only in the induc-
tion, but probably also in the maintenance, of BBB character-
istics in CNS endothelial cells have improved our level of
understanding of the mechanisms involved in BBB maturation
and maintenance. This knowledge will allow in vitro BBB
models to be improved, which is urgently needed for tests of
BBB permeability to chemicals or large-molecular-weight pro-
teins, transmigration of inflammatory cells, treatments with
cytokines and genetic manipulation in vitro (Paolinelli et al.
2013). In addition, this knowledge will enable CNS pathologies
to be targeted by therapeutic strategies aimed at repairing the
BBB. This might in principle be successful, as has been dem-
onstrated by our recent observation that clinical benefit can be
achieved in an animal model for MS by sealing BBB tight
junctions through the ectopic expression of the tight-junctional
protein claudin-1 in BBB endothelium (Pfeiffer et al. 2011). In
this study, we found that the ectopic expression of claudin-1 at
the BBB significantly reduces BBB leakiness and the disease
burden during the chronic phase of the disease and hence that
BBB dysfunction is a potential key event that contibutes to
clinical disease in the chronic phase of neuroinflammatory
disorders such as MS. The study further suggests that stabi-
lization of BBB function will be beneficial in treating
neuroinflammatory diseases (Pfeiffer et al. 2011).
Improved in vitro BBB models and inducible transgenic
mouse models will allow the delineation of the molecular mech-
anisms involved in BBB differentiation andmaintenance and the
discovery of mechanisms dysregulated in CNS pathology lead-
ing to BBB dysfunction. The challenge ahead is to unravel the
spatio-temporal involvement of distinct molecular cues and their
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cellular sources, e.g., pericytes, astroglial cells and neuroblasts,
in inducing and maintaining BBB characteristis in CNS micro-
vascular endothelial cells in vivo.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License, which permits any use, distribution and
reproduction in any medium, provided the original author(s) and the
source are credited.
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